These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10881509)

  • 1. [New domestic phospholipid preparation "Fosfogliv" as an effective treatment for patients with acute viral hepatitis].
    Uchaĭkin VF; Luchshev VI; Zharov SN; Kovalev OB; Ipatova OM; Tikhonova EG; Torkhovskaia TI; Kniazhev VA; Dunaevskiĭ OA; Archakov AI
    Klin Med (Mosk); 2000; 78(5):39-42. PubMed ID: 10881509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phosphogliv: mechanism of therapeutic action and clinical efficacy].
    Archakov AI; Sel'tsovskiĭ AP; Lisov VI; Tsyganov DI; Kniazhev VA; Ipatova OM; Torkhovskaia TI
    Vopr Med Khim; 2002; 48(2):139-53. PubMed ID: 12189622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with natural interferon (alfaferone) in clinical practice--our experience].
    Dybowska D; Halota W
    Przegl Epidemiol; 2007; 61(1):17-22. PubMed ID: 17702434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatoprotective action of phosphogliv in surgery of patients with chronic calculous cholecystitis].
    Uchaĭkin VF; Gal'perin EI; Kniazhev VA; Dokuchaev KV; Torkhovskaia TI; Kovalev OB; Ipatova OM; Guseva MK; Tikhonova EG; Archakov AI
    Khirurgiia (Mosk); 2000; (3):14-7. PubMed ID: 10761375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lamivudine therapy in patients with severe acute hepatitis B].
    Roznovský L; Orságová I; Kloudová A; Mrázek J
    Klin Mikrobiol Infekc Lek; 2007 Apr; 13(2):59-65. PubMed ID: 17599294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [When and how to treat hepatitis B and C?].
    Pache I; Hess J; Gonvers JJ; Moradpour D
    Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tri-infection: successful treatment of a patient infected with HIV and hepatitis B and C viruses--a case report.
    Johanson F
    AIDS Read; 2004 Jul; 14(7):389-94. PubMed ID: 15282868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C and B viruses: the new opportunists in HIV infection.
    Chung RT
    Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapy.
    Dore GJ
    AIDS Read; 2004 Jul; 14(7):392. PubMed ID: 15282869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of viral hepatitis in HIV-HBV-HCV co-infected patients].
    Manero E; Frider B; Landeira G
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S59-60; discussion S74-82. PubMed ID: 16862864
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
    Wang SS; Chou NK; Chi NH; Hsu RB; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Lai MY; Chu SH
    Transplant Proc; 2006 Sep; 38(7):2138-40. PubMed ID: 16980024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of the values of immune response mediators in patients with acute hepatitis C receiving combined antiviral therapy].
    Sobchak DM; Korochkina OV; Sobolevskaia OL
    Klin Med (Mosk); 2006; 84(12):47-50. PubMed ID: 17294884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L; Poznańska H; Rychalska B
    Przegl Epidemiol; 1981; 35(4):471-7. PubMed ID: 6803308
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of chronic hepatitis B and C in HIV-coinfected patients.
    Soriano V; Barreiro P; Nuñez M
    J Antimicrob Chemother; 2006 May; 57(5):815-8. PubMed ID: 16556638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.